Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Corporate earnings stories

Nov 6, 2026

Moderna posts first quarterly profit in two years, raises revenue forecast

Moderna swung to profit in Q3 2026, driven by strong international COVID-19 vaccine sales and partnership payments, and raised its full-year revenue guidance. The company also highlighted momentum for its mRNA-based cancer vaccine pipeline.

Nov 6, 2026·5 sources
00

Humana raises annual profit forecast on improved cost management

Humana lifted its full-year profit outlook after third-quarter revenue jumped 26% to $41.16 billion, beating Wall Street estimates, driven by better medical cost management in its Medicare Advantage business.

Nov 6, 2026·2 sources
00
Nov 5, 2026

Cigna raises 2026 profit outlook on insurance and specialty pharmacy strength

Cigna raised its annual profit forecast after beating third-quarter results, driven by gains in its specialty-pharmacy and health-services businesses, though its pharmacy benefits manager Express Scripts remains a drag.

Nov 5, 2026·4 sources
00
Nov 3, 2026

Pfizer raises 2026 outlook on strong demand for non-Covid drugs

Pfizer raised its full-year profit and revenue outlook after third-quarter results beat estimates, driven by growing demand for newly launched and acquired medicines as Covid product sales decline.

Nov 3, 2026·4 sources
00

Bayer raises 2026 profit outlook on strong pharmaceutical demand

Bayer AG raised its annual profit outlook after better-than-expected third-quarter performance driven by demand for newer drugs in its pharmaceuticals business.

Nov 3, 2026·2 sources
00

Philips reaches preliminary DOJ settlement over sleep and respiratory device recall

Dutch medical device manufacturer Philips has reached a preliminary agreement with the US Department of Justice to resolve investigations linked to its 2021 global recall of sleep and respiratory-care devices. The company booked a €288 million provision in Q3 related to the settlement.

Nov 3, 2026·3 sources
00
Nov 2, 2026

Teva Pharmaceutical beats Q3 profit forecasts, raises 2026 revenue guidance

Israeli drugmaker Teva Pharmaceutical Industries reported third-quarter profit that exceeded analyst expectations, driven by strong sales of three branded medicines that offset declines in generic drugs. The company raised its full-year 2026 revenue estimates following the results.

Nov 2, 2026·3 sources
00
Oct 30, 2026

AbbVie raises annual profit forecast on strong immunology drug sales

AbbVie raised its full-year profit forecast after beating third-quarter expectations, driven by strong demand for its newer immunology and neuroscience drugs as the company navigates the Humira patent cliff.

Oct 30, 2026·2 sources
00
Oct 28, 2026

Boston Scientific cuts outlook after cyberattack impacts operations

Boston Scientific lowered its full-year sales outlook to $5.45-5.55 billion from $5.44-5.64 billion and cut adjusted EPS guidance after a cyberattack disrupted operations, sending shares down.

Oct 28, 2026·2 sources
00
Oct 27, 2026

Cipla misses Q2 profit forecast on US weakness, shares slip

Indian drugmaker Cipla reported second-quarter earnings that missed profit expectations due to weakness in its US business, causing its shares to decline. The disappointing results reflect challenges in the company's American operations.

Oct 27, 2026·1 source
00

Novartis raises profit guidance despite $1.9 billion drug trial setback

Novartis increased its full-year core profit outlook for the third time in 2026, driven by growth of new medicines, but took a $1.9 billion write-down for neuromuscular drug candidate del-desiran following trial failure.

Oct 27, 2026·2 sources
00
Oct 21, 2026

Elevance Health raises 2026 profit forecast on lower medical costs

Health insurer Elevance raised its full-year profit guidance after a better-than-expected third quarter, with medical loss ratio coming in below estimates at 90.6%. The company now expects at least $29 adjusted earnings per share for the year and signaled earnings next year would top Wall Street estimates.

Oct 21, 2026·2 sources
00
Oct 13, 2026

UnitedHealth raises 2026 profit outlook as medical cost pressures ease

UnitedHealth Group raised its 2026 profit forecast and reported better-than-expected third-quarter earnings, signaling progress in managing elevated medical costs and its broader turnaround efforts.

Oct 13, 2026·4 sources
00
Oct 6, 2026

Samsung quarterly operating profit surges nearly ninefold on AI chip demand

Samsung Electronics reported third-quarter operating profit jumped nearly nine-fold year-over-year to 107.4 trillion won ($80 billion), beating analyst estimates, driven by strong demand for AI memory chips.

Oct 6, 2026·5 sources
00
Aug 25, 2026

Nvidia reports $96.2 billion quarterly revenue, up 106% year-over-year

Nvidia's fiscal Q2 2027 revenue reached $96.2 billion, a 106% increase from the prior year, with data center revenue up 117% to $89 billion. The company guided to $108 billion for the next quarter.

Aug 25, 2026·5 sources
00
Aug 13, 2026

Applied Materials forecast tops estimates but stock falls

Applied Materials delivered an estimate-beating revenue forecast for Q4 driven by AI chip demand, but shares fell after a strong rally, suggesting investor expectations had become too lofty.

Aug 13, 2026·2 sources
00
Aug 12, 2026

Foxconn reports 35% profit surge on AI hardware demand

Taiwan's Foxconn reported a 35% increase in second-quarter profit, beating analyst forecasts, driven by continued strong global demand for AI hardware and servers.

Aug 12, 2026·3 sources
00
Aug 10, 2026

Hims & Hers posts wider loss as shift to branded weight-loss drugs drives up costs

Hims & Hers Health reported a wider-than-expected second-quarter loss as the telehealth company's shift to branded weight-loss drugs drove up costs, sending shares down 6% in extended trading. The company plans to enter the peptides market before year-end.

Aug 10, 2026·3 sources
00
Aug 6, 2026

SoftBank quarterly profit falls 18% despite $8.2 billion gain from Intel investment

SoftBank Group reported an 18% drop in fiscal first quarter profit as higher costs offset investment gains, though the company received a significant boost from Intel's tripled share price during the quarter. The results highlight mixed performance in the technology investor's AI-focused portfolio.

Aug 6, 2026·3 sources
00
Aug 5, 2026

Uber stock falls 7% after weak profit forecast despite $10 billion robotaxi expansion plan

Uber Technologies shares dropped sharply after the company issued third-quarter earnings guidance below analyst expectations while announcing plans to invest over $10 billion in robotaxi expansion. The weak outlook comes amid uncertainty over its partnership with Waymo, though Uber maintains the Alphabet unit remains an important partner.

Aug 5, 2026·9 sources
00

CVS raises 2026 outlook as Aetna insurance unit shows recovery

CVS Health exceeded second-quarter earnings and revenue estimates and raised its full-year guidance, driven by better-than-expected medical costs in its Aetna insurance business. The results signal improvement in the struggling insurance division.

Aug 5, 2026·2 sources
00

Foxconn reports record monthly revenue of $29.3 billion in July, driven by AI product demand

Taiwanese electronics manufacturer Foxconn (Hon Hai Precision Industry Co.) posted record consolidated revenue exceeding NT$900 billion ($29.3 billion) in July 2026, marking a 54% year-over-year increase attributed to surging demand for artificial intelligence products.

Aug 5, 2026·8 sources
00
Aug 4, 2026

Pfizer beats revenue estimates on strength of Eliquis and other drugs

Pfizer reported second-quarter revenue that exceeded analyst expectations, driven by strong sales of blood thinner Eliquis and other key medications. The company raised the low end of its full-year revenue guidance.

Aug 4, 2026·1 source
00

Merck raises 2026 sales outlook on strength of newer drugs including Winrevair

Merck beat second-quarter estimates and boosted its 2026 sales forecast after strong demand for newer drugs like Winrevair helped drive revenues higher, though the company cut profit guidance due to deal-related charges.

Aug 4, 2026·2 sources
00
Aug 3, 2026

Palantir raises full-year forecast after US commercial revenue surges 150%

Palantir Technologies reported second-quarter sales far exceeding Wall Street estimates and raised its full-year revenue and income forecasts, with US commercial revenue more than doubling year-over-year. The stock surged 12% following the announcement.

Aug 3, 2026·2 sources
00

AMD Stock Falls Despite Beating Q2 Earnings Expectations and Forecasting Strong AI-Driven Revenue

Advanced Micro Devices reported second-quarter revenue of $11.54 billion, up 50% year-over-year and beating Wall Street estimates, with data center sales more than doubling. Despite projecting Q3 revenue of $13 billion above analyst expectations, the stock declined in extended trading as the strong results failed to exceed sky-high investor expectations.

Aug 3, 2026·7 sources
00
Jul 30, 2026

Amazon AWS revenue growth accelerates as cloud business surges

Amazon reported AWS revenue accelerated for a fifth straight quarter, with cloud computing growth easing investor concerns about AI infrastructure returns. The strong results sent shares up 12% and demonstrated clear demand for Amazon's custom AI chips.

Jul 30, 2026·7 sources
00
Jul 23, 2026

Intel forecast tops estimates as AI boom boosts data center demand

Intel's quarterly revenue forecast shattered Wall Street estimates, with the company raising spending plans over the next two years as data center growth accelerates. Revenue rose 25% in Q2, the fastest growth in 15 years.

Jul 23, 2026·3 sources
00

Mobileye Founder Amnon Shashua Plans to Step Down as CEO

Amnon Shashua, who founded Mobileye in 1999 and has served as CEO since, announced he will step down as the autonomous-driving technology company pushes into robotaxi services and robotics. The leadership transition, combined with disappointing third-quarter guidance, sent shares down about 15% despite strong Q2 results.

Jul 23, 2026·7 sources
00
Jul 22, 2026

ServiceNow raises annual forecast as AI bookings surpass $1 billion

ServiceNow reported better-than-expected quarterly results and raised its annual subscription revenue forecast for the second time, driven by AI-powered software demand with AI bookings exceeding $1 billion.

Jul 22, 2026·4 sources
00
Jul 15, 2026

ASML to Award €20,000 Stock Bonus to 45,000 Employees Amid Record AI-Driven Chip Sales

Dutch chip equipment maker ASML announced it will grant all employees a one-time €20,000 restricted stock award vesting in 2030, contingent on continued employment. The bonus follows the company raising its full-year sales outlook to €43-45 billion as AI demand drives record chip equipment orders.

Jul 15, 2026·7 sources
00
Jul 13, 2026

TSMC Q2 Revenue Surges 36% to $39.6 Billion, Beating Expectations on Strong AI Chip Demand

Taiwan Semiconductor Manufacturing Co. reported second-quarter revenue of $39.63 billion, a 36% year-over-year increase that exceeded market expectations and signals continued strong demand for AI hardware.

Jul 13, 2026·2 sources
00
Jun 8, 2026

Block raises 2026 profit guidance after Q2 earnings beat, driven by Cash App and Square growth despite Bitcoin profit decline

Block Inc. reported second-quarter 2026 results that exceeded Wall Street expectations and raised its full-year profit outlook, driven by strong performance in Cash App and Square businesses. However, Bitcoin ecosystem gross profit fell 31% following Cash App fee cuts, leading to mixed stock market reaction.

Jun 8, 2026·9 sources
00
May 9, 2026

Block Reports $308.7 Million Net Loss Despite Beating Adjusted Profit Expectations

Block (formerly Square) posted a $308.7 million net loss for Q1 2026 but beat Wall Street's adjusted profit expectations and raised its full-year gross profit forecast, sending shares up nearly 8% after hours.

May 9, 2026·2 sources
00
May 7, 2026

Novo Nordisk Reports Positive Earnings on Oral Wegovy Development Progress

Novo Nordisk's stock price and earnings received a boost following less-negative news about the development of an oral version of its blockbuster weight loss drug Wegovy, marking progress in the company's efforts to create a pill formulation.

May 7, 2026·1 source
00
May 3, 2026

Eli Lilly Raises 2026 Guidance as GLP-1 Drug Demand Surges in Q1

Eli Lilly reported strong Q1 2026 financial results driven by massive growth in Mounjaro and Zepbound sales, leading the company to raise its full-year guidance amid surging demand for GLP-1 medications.

May 3, 2026·1 source
00

Top claims

  • ▪Moderna reported Q3 2026 revenue of $1.3 billion, representing a 29% increase from Q3 2025 and exceeding Wall Street analyst expectations
  • ▪Moderna and partner Merck & Co. reported clinical data showing their mRNA skin cancer vaccine intismeran combined with Keytruda reduced melanoma recurrence or death risk by 42%
  • ▪Fidelity tripled its Moderna investment since September 2025 to become Moderna's largest shareholder, while Baillie Gifford reduced its stake to about 4.5%

People involved

Robert F. Kennedy Jr.Jon RonsonAmnon Shashua

Subtopics

Pharmaceutical Industry11Compute, chips & AI infrastructure10Pharmaceutical earnings7AI Data Center Gold Rush5Healthcare industry5Pharma5AI startups4Health insurance4Healthcare costs4Semiconductor industry4Semiconductor manufacturing4Cancer & Oncology3Drug development3GLP-1 medications3Public healthcare3Stock market performance3Wall Street3Autonomous Vehicles2Bitcoin2Bitcoin adoption2Business & enterprise AI2Cancer and Cancer Treatment2Cancer treatment2Clinical trials2

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories